Antibody conjugates with two or more covalently linked FC region

Details Antibody conjugates with two or more covalently linked FC region Antibody conjugates with two or more covalently linked FC region

1995-06-01

1997-10-28

Kim, Kay A.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

4241791, 4241331, 4241361, 5303911, 5303913, 5303917, 5303919, A61K 3944, C07K 1702, C07K 1646

Patent

active

056815662

ABSTRACT:
Synthetic antibody derivatives having at least two F regions covalently linked so as to enhance Fc activity for example effector recruitment. The use of such derivatives in the treatment of conditions where killing of cells is required for example cancer therapy. Methods for the preparation of derivatives are also described.

REFERENCES:
patent: 3928580 (1975-12-01), Fontaine
patent: 4344938 (1982-08-01), Sedlacek et al.
patent: 4479895 (1984-10-01), Auditore-Hargreaves
patent: 4676980 (1987-06-01), Segal et al.
J. Siegelman et al, Cell Tissue Res., 248: 599-605 (1987) "Characterization of immunoglobulin G-Fc receptor activity in the outflow system of the cerebrospinal fluid".
T. Kitagawa, et al, Chem. Pharm. Bull. 29(4) 1130-1135 (1981) "Preparation and Characterization of Hetero-bifunctional Cross-linking Reagents for Protein Modifications".
15-Immunochemistry, vol. 110 (1989): 552-553 Abstract No. 210562a.
15-Immunochemistry, vol. 107 (1987) abstract #37765g ( of Siegelman et al above).
G.T. Stevenson and M.J. Glennie, Cancer Surveys, vol. 4 No. 1 (1985) "Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target".
M.W. Fanger, et al, Immunology Today, vol. 10, No. 3 (1989) "Cytotoxicity mediated by human Fc receptors for IgG", pp. 92-99.
F.K. Stevenson et al, Br. J. Cancer, 50, 407-413 (1984) "Consumption of Monoclonal Anti-idiotypic Antibody by Neoplastic B Lymphocytes: A Guide for Immunotherapy".
T. J. Elliott et al, The Journal of Immunology, vol. 138, 981-988, Feb. 2, 1987 "Analysis Of The Interaction Of Antibodies With Immunoglobulin Idiotypes On Neoplastic B Lymphocytes: Implications For Immunotherapy".
G.T. Stevenson et al, Bioscience Reports 5, 991-998 (1985) "Preparation and Properties of FabIgG, a Chimeric Univalent Antibody Designed To Attack Tumour Cells".
J. Stephen etal, Biochem. J. (1966) 101,717 "Separation of Antigens by Immunological Specificity".
L. Riechmann et al, Nature, vol. 332, Mar. 24, 1988 "Reshaping Human Antibodies for Therapy".
Van Dijk et al. (1989) Int. J. Cancer 44 738-743.
Liu et al (1985) Proc. Natl. Acad. Sci. 82: 8648-8652.
Stevenson et al. (1989) Anti-Cancer Drug Design 3:219-230.
Dictionary of Immunology eds. Herbert, WJ. et al Third edition, Blackwell Scientific Publications Boston, 1985 pp. 79 and 108.
Immunology Eisen, Harper & Row, Publishers Hagerstown, MD 1974 pp. 409-410.
Hermentin et al (1988) Behring Inst. Mitt. 82:197-215.
Harris et al. (1993) TIBTECH II: 42-44.
Osband et al (1990) Immunology Today 11(6): 193-195.
Waldmann (1991) Science 252: 1657-1662.
Gould et al. (1989) J. Natl. Cancer Inst. 81(10): 775-781.
Microbiology, 2nd edition Reprint as Immunology Davis et al, 1974, Harper & Row, Publishers Inc. pp. 416-418.

Affiliated with

Also associated with

Rating

Antibody conjugates with two or more covalently linked FC region does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody conjugates with two or more covalently linked FC region, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody conjugates with two or more covalently linked FC region will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1024276